@prefix this: . @prefix sub: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-gda: . @prefix dgn-void: . sub:head { this: np:hasAssertion sub:assertion ; np:hasProvenance sub:provenance ; np:hasPublicationInfo sub:publicationInfo ; a np:Nanopublication . } sub:assertion { dgn-gda:DGNe89cd9101a8d62d12df95343a93c0cf4 sio:SIO_000628 miriam-gene:183 , lld:C0004153 ; a sio:SIO_001120 . } sub:provenance { sub:assertion dcterms:description "[Transfection with GPE nanoparticle carrying AGT shRNA can stably lower the blood pressure and improve the atherosclerotic lesions which lead to the delayed development of early atherosclerotic lesions in hypertension rats with concomitant atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ; wi:evidence dgn-void:source_evidence_predicted ; sio:SIO_000772 miriam-pubmed:22977667 ; prov:wasDerivedFrom dgn-void:RGD ; prov:wasGeneratedBy eco:ECO_0000218 . dgn-void:RGD pav:importedOn "2017-01-25"^^xsd:date . dgn-void:source_evidence_predicted a eco:ECO_0000266 ; rdfs:comment "Gene-disease associations inferred from animal model manually asserted gene-disease associations."@en ; rdfs:label "DisGeNET evidence - PREDICTED"@en . } sub:publicationInfo { this: dcterms:created "2017-10-17T13:10:21+02:00"^^xsd:dateTime ; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup ; dcterms:subject sio:SIO_000983 ; prv:usedData dgn-void:disgenetv3.0rdf ; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v5.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v5.0.0" . }